WHO ICTRP trial
An open-label study in patients with advanced cancer.
EUCTR2017-002243-15-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-002243-15-GB |
|---|---|
| Public title | An open-label study in patients with advanced cancer. |
| Scientific title | A Phase I/II Open-Label, Multi-center Study of the Safety and Efficacy of IMCnyeso, an HLA-A* 0201-Restricted, NY-ESO-1 and LAGE-1A-specific soluble T Cell Receptor and Anti-CD3 Bi-specific Molecule, as a Single Agent in HLA-A* 0201 Positive Patients With Advanced NY-ESO-1 and/or LAGE-1A Positive… |
| Primary sponsor | Immunocore Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Canada;United Kingdom |
| Conditions | HLA-A*0201 positive patients with advanced antigen-positive cancer with a histologic diagnosis of Non small cell lung carcinoma (NSCLC), melanoma, urothelial carcinoma, or synovial sarcoma with antigen positivity for NY-ESO-1 and/or LAGE-1A… |
| Interventions | Product Name: IMCnyeso Product Code: IMCnyeso Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: IMCNYESO Current Sponsor code: IMCNYESO Concentration unit: mg/ml milligram(s)/millilitre Concentration type… |
| Registration date | Apr 7, 2018 |
| Target size | 63 |
| Secondary IDs | IMCnyeso-101 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: